Skin disease disability: measuring its magnitude

Area of Science:

• Dermatology
• Quality of Life Research
• Health Outcomes Measurement

Background:

• Skin diseases cause significant discomfort and profoundly affect patients' lives.
• Measuring the impact of skin conditions on quality of life is crucial for clinical, research, and policy purposes.
• Existing general health questionnaires can be adapted, but disease-specific measures offer greater precision.

Purpose of the Study:

• To highlight the need for validated methods to assess the quality of life impact of skin diseases.
• To review various tools available for measuring the effects of dermatological conditions on patients' lives.
• To emphasize the utility of disease-specific instruments like the Dermatology Life Quality Index (DLQI).

Main Methods:

• Review of general health questionnaires (e.g., Sickness Impact Profile, SF-36).
• Discussion of disease-specific instruments (e.g., Psoriasis Disability Index) and dermatology-specific measures (e.g., DLQI).
• Evaluation of utility measures in dermatological contexts.

Main Results:

• The Dermatology Life Quality Index (DLQI) has successfully quantified the substantial impact of inflammatory skin diseases on patients.
• The DLQI has demonstrated improvements in quality of life following systemic therapy and inpatient management.
• A pediatric version of the DLQI has been developed, expanding its applicability.

Conclusions:

• Validated tools like the DLQI are essential for understanding and quantifying the burden of skin disease.
• Data from quality of life assessments can advocate for better skin disease management and resource allocation.
• Accurate measurement of quality of life impacts underscores the importance of addressing dermatological conditions effectively.